| Literature DB >> 35012494 |
Agata Anna Wykrota1, Isabel Weinstein2, Loïc Hamon2, Loay Daas2, Elias Flockerzi2, Shady Suffo2, Berthold Seitz2.
Abstract
BACKGROUND: With the increasing demand for corneas, eye banks must optimize the tissue donation, collection, and selection process. This retrospective monocentric study analyzed the approval rates for corneal donation and the origin of and reasons for discarding donor corneas from 2010 to 2019.Entities:
Keywords: Cornea; Corneal transplantation; Eye bank; Keratoplasty; Organ donation; Organ donor card
Mesh:
Year: 2022 PMID: 35012494 PMCID: PMC8745546 DOI: 10.1186/s12886-022-02248-7
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Fig. 1Results of the 2020 nationwide representative survey “Knowledge, attitude and behavior of the general population (aged between 14 and 75 years) for organ and tissue donation” run by the Federal Centre for Health Education on 4001 persons asked in Germany concerning the documentation of the decision to donate organs and tissues [9]
Fig. 2Number of lamellar and penetrating keratoplasties between 2008 and 2019 according to the German Keratoplasty Registry. Note: The term posterior lamellar keratoplasty includes both Descemet membrane endothelial keratoplasty and Descemet stripping automated endothelial keratoplasty
Fig. 3Total number of keratoplasties performed at the UKS Department of Ophthalmology between 2006 and 2020
List of the contraindications to corneal explantation
| Unknown cause of death or significant disease of unknown etiology in the medical history | |
| Viral donor diseases: HIV (human immunodeficiency virus) infection, hepatitis B/C, HTLV I/II (human T-lymphotropic virus) or special risk factors for these infections | |
| Bacterial donor diseases: syphilis or other chronic persistent bacterial infections: brucellosis, typhus, rickettsiosis, leprosy, relapsing fever, melioidosis, tularemia | |
| Protozoonotic donor diseases: babesiosis, trypanosomiasis (e.g., Chagas disease), leishmaniasis | |
| Active systemic infections: bacterial, viral, fungal, parasitic or of unknown cause | |
| Fungal sepsis or sepsis with multi-resistant germs (a bacterial sepsis with the usual spectrum is not a contraindication) | |
| Disorders of the central nervous system (CNS) of unclear cause: Alzheimer’s disease, Parkinson’s disease, unclear rapidly progressing dementia, multiple sclerosis, amyotrophic lateral sclerosis, retroviral CNS disease | |
| Hematological neoplasias, leukemias, lymphomas | |
| Ophthalmic donor diseases with visible changes in the cornea, condition after corneal surgery, local infection, tumors of the eye | |
| Status after post-exposure vaccination against rabies within 12 months, status after live vaccines within 4 weeks | |
| Risk of disease transmission through prions: patients after dura mater-, cornea-, sclera-, hetero- or xenotransplantation, recipients of pituitary hormones, diagnosed Creutzfeldt-Jacob disease in the donor or in the family history | |
| Premortal use of substances that could have harmful effects on the recipient due to the transplant (e.g., poisons, heavy metals) | |
| Donors with premortal plasma thinning of more than 50% due to previous transfusions (plasma dilution up to 22.5 ml per kg of body weight is acceptable) | |
| Temporary exclusion: 2 years after healing of salmonellosis, Q-fever, tuberculosis, leptospirosis; 4 years after malaria cured; 4 weeks after measles, rubella, Varicella-zoster virus (VZV) or other serious viral diseases have healed | |
| Risk of ZIKV (Zika virus) infection | |
| Information about other unclear diseases; colonization or infection with Methicillin-resistant Staphylococcus aureus (MRSA)/ Extended spectrum beta-lactamases (ESBL)/ Vancomycin-resistant Staphylococcus aureus (VRSA) | |
| Indications of incomplete or unreliable medical history, doubts as to the accuracy of the information | |
| Additional information: natural death or confiscation by criminal police, diabetes mellitus, condition after chemotherapy and radiation therapy | |
| Coronavirus disease 2019 since March 2020 |
Fig. 4Number of deceased persons, refusals and approvals to the corneal donation and corneas removed (1 donor = 2 corneas) at the UKS in Homburg/Saar between 2010 and 2019
Fig. 5Percentage of cornea explantations, as well as contraindications and refusals to corneal donations in the years 2010–2019. The red line shows the percentage of consents of relatives to corneal explantation, including a small proportion of contraindications
Fig. 6Data showing the units with most recorded corneal donations at the UKS – pulmonology and cardiology, intensive care, neurology, neurosurgery, and palliative wards. Note: The palliative unit exists since October 2016
Fig. 7Number of donated corneas from UKS, Luxembourg and the external facilities to our Eye Bank, as well as corneas processed in other Eye Banks and bought by the UKS Eye Bank from 2010 to 2019. Note: The official cooperation with Luxembourg did not exist before 2013
Fig. 8Percentage of the corneas obtained from UKS, and the corneas obtained from external facilities but processed in Homburg compared to the corneas processed in different Eye Banks and bought ready-to-use by the Eye Bank of the UKS in the years 2010–2019
Fig. 9Number of corneas ready-to-use that have been bought from external Eye Banks in the years 2010–2019. BIS = Bio Implant Services; GBM-V = Gewebebank, Mecklenburg-Vorpommern, Rostock; DGFG = German Society for Tissue Transplantation (Deutsche Gesellschaft für Gewebetransplantation). Note: BIS is responsible for the human leukocyte antigen-matched corneas exclusively; number 6 – Others – represents delivery facilities not mentioned before
Fig. 10Percentage and reasons for discarding corneas since 2009 – overall number of tissue contamination, endothelial cell count (ECC), conjunctival swab and serology being the main reasons for corneal rejection